JAK3 c.1715C>T ;(p.A572V)

Variant ID: 19-17948009-G-A

NM_000215.3(JAK3):c.1715C>T;(p.A572V)

This variant was identified in 94 publications

View GRCh38 version.




Publications:


Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: JAK3: 1715C>T; Ala572Val
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Clonal hematopoiesis is not significantly associated with COVID-19 disease severity.

Blood
Zhou, Yifan Y; Shalhoub, Ruba R; Rogers, Stephanie N SN; Yu, Shiqin S; Gu, Muxin M; Fabre, Margarete A MA; Quiros, Pedro M PM; Shin, Tae-Hoon TH; Diangson, Arch A; Deng, Wenhan W; Anand, Shubha S; Lu, Wenhua W; Cullen, Matthew M; Godfrey, Anna L AL; Preller, Jacobus J; Hadjadj, Jerome J; Jouanguy, Emmanuelle E; Cobat, Aurélie A; Abel, Laurent L; Rieux-Laucat, Frederic F; Terrier, Benjamin B; Fischer, Alain A; Novik, Lara L; Gordon, Ingelise J IJ; Strom, Larisa L; Gaudinski, Martin R MR; Lisco, Andrea A; Sereti, Irini I; Gniadek, Thomas J TJ; Biondi, Andrea A; Bonfanti, Paolo P; Imberti, Luisa L; Dalgard, Clifton L CL; Zhang, Yu Y; Dobbs, Kerry K; Su, Helen C HC; Notarangelo, Luigi D LD; Wu, Colin O CO; Openshaw, Peter J M PJM; Semple, Malcolm G MG; Mallat, Ziad Z; Baillie, Kenneth K; Dunbar, Cynthia E CE; Vassiliou, George S GS
Publication Date: 2022-10-06

Variant appearance in text: JAK3: A572V
PubMed Link: 35839449
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.

Haematologica
Veloza, Luis L; Cavalieri, Doriane D; Missiaglia, Edoardo E; Ledoux-Pilon, Albane A; Bisig, Bettina B; Pereira, Bruno B; Bonnet, Christophe C; Poullot, Elsa E; Quintanilla-Martinez, Leticia L; Dubois, Romain R; Llamas-Gutierrez, Francisco F; Bossard, Céline C; De Wind, Roland R; Drieux, Fanny F; Fontaine, Juliette J; Parrens, Marie M; Sandrini, Jeremy J; Fataccioli, Virginie V; Delfau-Larue, Marie-Hélène MH; Daniel, Adrien A; Lhomme, Faustine F; Clément-Filliatre, Lauriane L; Lemonnier, François F; Cairoli, Anne A; Morel, Pierre P; Glaisner, Sylvie S; Joly, Bertrand B; El Yamani, Abderrazak A; Laribi, Kamel K; Bachy, Emmanuel E; Siebert, Reiner R; Vallois, David D; Gaulard, Philippe P; Tournilhac, Olivier O; De Leval, Laurence L
Publication Date: 2022-06-16

Variant appearance in text: JAK3: 1715C>T; Ala572Val
PubMed Link: 35708139
Variant Present in the following documents:
  • 2022_281226_VELOZA_SUPPL.pdf
View BVdb publication page



Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.

Cancer Science
Fukuhara, Suguru S; Oshikawa-Kumade, Yuji Y; Kogure, Yasunori Y; Shingaki, Sumito S; Kariyazono, Hirokazu H; Kikukawa, Yoshiya Y; Koya, Junji J; Saito, Yuki Y; Tabata, Mariko M; Yoshifuji, Kota K; Mizuno, Kota K; Miyagi-Maeshima, Akiko A; Matsushita, Hiromichi H; Sugiyama, Masanaka M; Ogawa, Chitose C; Inamoto, Yoshihiro Y; Fukuda, Takahiro T; Sugano, Masato M; Yamauchi, Nobuhiko N; Minami, Yosuke Y; Hirata, Makoto M; Yoshida, Teruhiko T; Kohno, Takashi T; Kohsaka, Shinji S; Mano, Hiroyuki H; Shiraishi, Yuichi Y; Ogawa, Seishi S; Izutsu, Koji K; Kataoka, Keisuke K
Publication Date: 2022-08

Variant appearance in text: JAK3: A572V
PubMed Link: 35579198
Variant Present in the following documents:
  • CAS-113-2763-s003.xlsx, sheet 6
View BVdb publication page



Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia.

Blood Science (Baltimore, Md.)
Zhu, Haichuan H; Dong, Bingjie B; Zhang, Yingchi Y; Wang, Mei M; Rao, Jianan J; Cui, Bowen B; Liu, Yu Y; Jiang, Qian Q; Wang, Weitao W; Yang, Lu L; Yu, Anqi A; Li, Zongru Z; Liu, Chao C; Zhang, Leping L; Huang, Xiaojun X; Zhu, Xiaofan X; Wu, Hong H
Publication Date: 2022-01

Variant appearance in text: JAK3: A572V
PubMed Link: 35399540
Variant Present in the following documents:
  • bls-4-16-s005.xlsx, sheet 2
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: JAK3: Ala572Val
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



The JAK/STAT signaling pathway: from bench to clinic.

Signal Transduction And Targeted Therapy
Hu, Xiaoyi X; Li, Jing J; Fu, Maorong M; Zhao, Xia X; Wang, Wei W
Publication Date: 2021-11-26

Variant appearance in text: JAK3: A572V
PubMed Link: 34824210
Variant Present in the following documents:
  • Main text
View BVdb publication page



Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers.

Cancers
Li, Boheng B; Wan, Qin Q; Li, Zhubo Z; Chng, Wee-Joo WJ
Publication Date: 2021-10-14

Variant appearance in text: JAK3: A572V
PubMed Link: 34680295
Variant Present in the following documents:
  • Main text
  • cancers-13-05147.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: JAK3: A572V
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



[Prognostic analysis of patients with mutations in the JAK/STAT signaling pathway in adult acute lymphoblastic leukemia].

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
Fan, W J WJ; Xu, T T TT; Guo, J J JJ; Li, Y F YF; Jiang, Z X ZX
Publication Date: 2021-07-14

Variant appearance in text: JAK3: A572V
PubMed Link: 34455748
Variant Present in the following documents:
  • cjh-42-07-594.pdf
View BVdb publication page



Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS).

Cancer Management And Research
Zhu, Lifen L; Xie, Shufang S; Yang, Chen C; Hua, Nanni N; Wu, Yi Y; Wang, Lei L; Ni, Wanmao W; Tong, Xiangmin X; Fei, Min M; Wang, Shibing S
Publication Date: 2021

Variant appearance in text: JAK3: A572V
PubMed Link: 34239326
Variant Present in the following documents:
  • Main text
  • cmar-13-5275.pdf
View BVdb publication page



Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Cancers
Klein, Klara K; Stoiber, Dagmar D; Sexl, Veronika V; Witalisz-Siepracka, Agnieszka A
Publication Date: 2021-05-26

Variant appearance in text: JAK3: A572V
PubMed Link: 34073410
Variant Present in the following documents:
  • Main text
  • cancers-13-02611.pdf
View BVdb publication page



Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer
Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA
Publication Date: 2021-05

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 33704917
Variant Present in the following documents:
  • TCA-12-1271-s003.xls, sheet 1
View BVdb publication page



Janus Kinase Mutations in Mice Lacking PU.1 and Spi-B Drive B Cell Leukemia through Reactive Oxygen Species-Induced DNA Damage.

Molecular And Cellular Biology
Lim, Michelle M; Batista, Carolina R CR; de Oliveira, Bruno R BR; Creighton, Rachel R; Ferguson, Jacob J; Clemmer, Kurt K; Knight, Devon D; Iansavitchous, James J; Mahmood, Danish D; Avino, Mariano M; DeKoter, Rodney P RP
Publication Date: 2020-08-28

Variant appearance in text: JAK3: A572V
PubMed Link: 32631903
Variant Present in the following documents:
  • Main text
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: JAK3: A572V
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



Development and validation of a targeted gene sequencing panel for application to disparate cancers.

Scientific Reports
McCabe, Mark J MJ; Gauthier, Marie-Emilie A MA; Chan, Chia-Ling CL; Thompson, Tanya J TJ; De Sousa, Sunita M C SMC; Puttick, Clare C; Grady, John P JP; Gayevskiy, Velimir V; Tao, Jiang J; Ying, Kevin K; Cipponi, Arcadi A; Deng, Niantao N; Swarbrick, Alex A; Thomas, Melissa L ML; Lord, Reginald V RV; Johns, Amber L AL; Kohonen-Corish, Maija M; O'Toole, Sandra A SA; Clark, Jonathan J; Mueller, Simon A SA; Gupta, Ruta R; McCormack, Ann I AI; Dinger, Marcel E ME; Cowley, Mark J MJ; ,
Publication Date: 2019-11-19

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 31745186
Variant Present in the following documents:
  • 41598_2019_52000_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues.

Frontiers In Molecular Biosciences
Dehghani, Mehdi M; Rosenblatt, Kevin P KP; Li, Lei L; Rakhade, Mrudula M; Amato, Robert J RJ
Publication Date: 2019

Variant appearance in text: JAK3: Ala572Val
PubMed Link: 31681791
Variant Present in the following documents:
  • Data_Sheet_5.pdf
View BVdb publication page



PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors.

Oncotarget
Smith, Amanda M AM; Zhang, Christine R C CRC; Cristino, Alexandre S AS; Grady, John P JP; Fink, J Lynn JL; Moore, Andrew S AS
Publication Date: 2019-10-08

Variant appearance in text: JAK3: A572V
PubMed Link: 31645898
Variant Present in the following documents:
  • Main text
View BVdb publication page



The LL-100 panel: 100 cell lines for blood cancer studies.

Scientific Reports
Quentmeier, Hilmar H; Pommerenke, Claudia C; Dirks, Wilhelm G WG; Eberth, Sonja S; Koeppel, Max M; MacLeod, Roderick A F RAF; Nagel, Stefan S; Steube, Klaus K; Uphoff, Cord C CC; Drexler, Hans G HG
Publication Date: 2019-06-03

Variant appearance in text: JAK3: A572V
PubMed Link: 31160637
Variant Present in the following documents:
  • Main text
View BVdb publication page



Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma.

Frontiers In Oncology
Cai, Qingqing Q; Cai, Jun J; Fang, Yu Y; Young, Ken H KH
Publication Date: 2019

Variant appearance in text: JAK3: A572V
PubMed Link: 31139570
Variant Present in the following documents:
  • Main text
View BVdb publication page



JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.

Oncology Reports
Liu, Jumei J; Liang, Li L; Li, Dong D; Nong, Lin L; Zheng, Yalin Y; Huang, Sixia S; Zhang, Bo B; Li, Ting T
Publication Date: 2019-06

Variant appearance in text: JAK3: A572V
PubMed Link: 31002364
Variant Present in the following documents:
  • Main text
  • or-41-06-3219.pdf
View BVdb publication page



Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL).

Journal Of Hematology & Oncology
Somasundaram, Nagavalli N; Lim, Jing Quan JQ; Ong, Choon Kiat CK; Lim, Soon Thye ST
Publication Date: 2019-03-15

Variant appearance in text: JAK3: A572V
PubMed Link: 30876435
Variant Present in the following documents:
  • Main text
View BVdb publication page



Prospects for pharmacological targeting of pseudokinases.

Nature Reviews. Drug Discovery
Kung, Jennifer E JE; Jura, Natalia N
Publication Date: 2019-07

Variant appearance in text: JAK3: A572V
PubMed Link: 30850748
Variant Present in the following documents:
  • Main text
View BVdb publication page



Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain.

Frontiers In Oncology
Raivola, Juuli J; Hammarén, Henrik M HM; Virtanen, Anniina T AT; Bulleeraz, Vilasha V; Ward, Alister C AC; Silvennoinen, Olli O
Publication Date: 2018

Variant appearance in text: JAK3: A572V
PubMed Link: 30560087
Variant Present in the following documents:
  • Main text
  • fonc-08-00560.pdf
View BVdb publication page



LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL).

Oncotarget
Hee, Yan Ting YT; Yan, Junli J; Nizetic, Dean D; Chng, Wee-Joo WJ
Publication Date: 2018-08-07

Variant appearance in text: JAK3: A572V
PubMed Link: 30159126
Variant Present in the following documents:
  • Main text
View BVdb publication page



"Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.

Frontiers In Oncology
Bousoik, Emira E; Montazeri Aliabadi, Hamidreza H
Publication Date: 2018

Variant appearance in text: JAK3: A572V
PubMed Link: 30109213
Variant Present in the following documents:
  • fonc-08-00287.pdf
View BVdb publication page



Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma.

Bmc Urology
Kim, Young Saing YS; Kim, Kyung K; Kwon, Ghee-Young GY; Lee, Su Jin SJ; Park, Se Hoon SH
Publication Date: 2018-07-31

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 30064409
Variant Present in the following documents:
  • 12894_2018_380_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Blood
Song, Tammy Linlin TL; Nairismägi, Maarja-Liisa ML; Laurensia, Yurike Y; Lim, Jing-Quan JQ; Tan, Jing J; Li, Zhi-Mei ZM; Pang, Wan-Lu WL; Kizhakeyil, Atish A; Wijaya, Giovani-Claresta GC; Huang, Da-Chuan DC; Nagarajan, Sanjanaa S; Chia, Burton Kuan-Hui BK; Cheah, Daryl D; Liu, Yan-Hui YH; Zhang, Fen F; Rao, Hui-Lan HL; Tang, Tiffany T; Wong, Esther Kam-Yin EK; Bei, Jin-Xin JX; Iqbal, Jabed J; Grigoropoulos, Nicholas-Francis NF; Ng, Siok-Bian SB; Chng, Wee-Joo WJ; Teh, Bin-Tean BT; Tan, Soo-Yong SY; Verma, Navin Kumar NK; Fan, Hao H; Lim, Soon-Thye ST; Ong, Choon-Kiat CK
Publication Date: 2018-09-13

Variant appearance in text: JAK3: A572V
PubMed Link: 30054295
Variant Present in the following documents:
  • Main text
View BVdb publication page



Integrative omics analyses broaden treatment targets in human cancer.

Genome Medicine
Sengupta, Sohini S; Sun, Sam Q SQ; Huang, Kuan-Lin KL; Oh, Clara C; Bailey, Matthew H MH; Varghese, Rajees R; Wyczalkowski, Matthew A MA; Ning, Jie J; Tripathi, Piyush P; McMichael, Joshua F JF; Johnson, Kimberly J KJ; Kandoth, Cyriac C; Welch, John J; Ma, Cynthia C; Wendl, Michael C MC; Payne, Samuel H SH; Fenyö, David D; Townsend, Reid R RR; Dipersio, John F JF; Chen, Feng F; Ding, Li L
Publication Date: 2018-07-27

Variant appearance in text: JAK3: A572V
PubMed Link: 30053901
Variant Present in the following documents:
  • 13073_2018_564_MOESM2_ESM.xlsx, sheet 3
View BVdb publication page



Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.

Blood Advances
Rivera-Munoz, Paola P; Laurent, Anouchka P AP; Siret, Aurelie A; Lopez, Cecile K CK; Ignacimouttou, Cathy C; Cornejo, Melanie G MG; Bawa, Olivia O; Rameau, Philippe P; Bernard, Olivier A OA; Dessen, Philippe P; Gilliland, Gary D GD; Mercher, Thomas T; Malinge, Sébastien S
Publication Date: 2018-07-10

Variant appearance in text: JAK3: A572V
PubMed Link: 29986854
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical and molecular characteristics of unicentric mediastinal Castleman disease.

Journal Of Thoracic Disease
Legras, Antoine A; Tallet, Anne A; Didelot, Audrey A; Cazes, Aurélie A; Danel, Claire C; Hin, Angela A; Borie, Raphaël R; Crestani, Bruno B; Castier, Yves Y; Bagan, Patrick P; Le Pimpec-Barthes, Françoise F; Riquet, Marc M; Blons, Hélène H; Mordant, Pierre P
Publication Date: 2018-04

Variant appearance in text: JAK3: A572V
PubMed Link: 29850111
Variant Present in the following documents:
  • Main text
View BVdb publication page



Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.

Japanese Journal Of Clinical Oncology
Naito, Yoichi Y; Takahashi, Hideaki H; Shitara, Kohei K; Okamoto, Wataru W; Bando, Hideaki H; Kuwata, Takeshi T; Kuboki, Yasutoshi Y; Matsumoto, Shingo S; Miki, Izumi I; Yamanaka, Takeharu T; Watanabe, Atsushi A; Kojima, Motohiro M
Publication Date: 2018-06-01

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 29659903
Variant Present in the following documents:
  • hyy052supplementaltable1ionver1.xls, sheet 1
View BVdb publication page



Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma.

Leukemia
Nairismägi, M -L M-; Gerritsen, M E ME; Li, Z M ZM; Wijaya, G C GC; Chia, B K H BKH; Laurensia, Y Y; Lim, J Q JQ; Yeoh, K W KW; Yao, X S XS; Pang, W L WL; Bisconte, A A; Hill, R J RJ; Bradshaw, J M JM; Huang, D D; Song, T L L TLL; Ng, C C Y CCY; Rajasegaran, V V; Tang, T T; Tang, Q Q QQ; Xia, X J XJ; Kang, T B TB; Teh, B T BT; Lim, S T ST; Ong, C K CK; Tan, J J
Publication Date: 2018-05

Variant appearance in text: JAK3: A572V
PubMed Link: 29434279
Variant Present in the following documents:
  • 41375_2017_4_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.

F1000Research
Vainchenker, William W; Leroy, Emilie E; Gilles, Laure L; Marty, Caroline C; Plo, Isabelle I; Constantinescu, Stefan N SN
Publication Date: 2018

Variant appearance in text: JAK3: A572V
PubMed Link: 29399328
Variant Present in the following documents:
  • Main text
  • f1000research-7-14282.pdf
View BVdb publication page



An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome.

Frontiers In Immunology
Sic, Heiko H; Speletas, Matthaios M; Cornacchione, Vanessa V; Seidl, Maximillian M; Beibel, Martin M; Linghu, Bolan B; Yang, Fan F; Sevdali, Eirini E; Germenis, Anastasios E AE; Oakeley, Edward J EJ; Vangrevelinghe, Eric E; Sailer, Andreas W AW; Traggiai, Elisabetta E; Gram, Hermann H; Eibel, Hermann H
Publication Date: 2017

Variant appearance in text: JAK3: A572V
PubMed Link: 29375547
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.

Blood
Degryse, Sandrine S; Bornschein, Simon S; de Bock, Charles E CE; Leroy, Emilie E; Vanden Bempt, Marlies M; Demeyer, Sofie S; Jacobs, Kris K; Geerdens, Ellen E; Gielen, Olga O; Soulier, Jean J; Harrison, Christine J CJ; Constantinescu, Stefan N SN; Cools, Jan J
Publication Date: 2018-01-25

Variant appearance in text: JAK3: A572V
PubMed Link: 29187379
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract.

Translational Oncology
Lee, Ji Yun JY; Kim, Kyung K; Sung, Hyun Hwan HH; Jeon, Hwang Gyun HG; Jeong, Byong Chang BC; Seo, Seong Il SI; Jeon, Seong Soo SS; Lee, Hyun Moo HM; Choi, Han-Yong HY; Kwon, Ghee-Young GY; Kim, Kyoung-Mee KM; Lee, Jeeyun J; Lim, Ho Yeong HY; Park, Se Hoon SH
Publication Date: 2018-02

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 29161613
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors.

Clinical Cancer Drugs
Martinez, G Steven GS; Ross, Jeremy A JA; Kirken, Robert A RA
Publication Date: 2016

Variant appearance in text: JAK3: A572V
PubMed Link: 29046866
Variant Present in the following documents:
  • Main text
View BVdb publication page



The promise of Janus kinase inhibitors in the treatment of hematological malignancies.

Cytokine
Senkevitch, Emilee E; Durum, Scott S
Publication Date: 2017-10

Variant appearance in text: JAK3: A572V
PubMed Link: 28277287
Variant Present in the following documents:
  • Main text
View BVdb publication page



Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.

Bmc Cancer
Bonfiglio, Silvia S; Vanni, Irene I; Rossella, Valeria V; Truini, Anna A; Lazarevic, Dejan D; Dal Bello, Maria Giovanna MG; Alama, Angela A; Mora, Marco M; Rijavec, Erika E; Genova, Carlo C; Cittaro, Davide D; Grossi, Francesco F; Coco, Simona S
Publication Date: 2016-08-30

Variant appearance in text: JAK3: A572V
PubMed Link: 27578032
Variant Present in the following documents:
  • Main text
  • 12885_2016_Article_2720.pdf
View BVdb publication page



Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas.

Leukemia
Nicolae, A A; Xi, L L; Pham, T H TH; Pham, T-A TA; Navarro, W W; Meeker, H G HG; Pittaluga, S S; Jaffe, E S ES; Raffeld, M M
Publication Date: 2016-11

Variant appearance in text: JAK3: A572V
PubMed Link: 27389054
Variant Present in the following documents:
  • Main text
  • nihms789777.pdf
View BVdb publication page



JAK-STAT signaling in cancer: From cytokines to non-coding genome.

Cytokine
Pencik, Jan J; Pham, Ha Thi Thanh HT; Schmoellerl, Johannes J; Javaheri, Tahereh T; Schlederer, Michaela M; Culig, Zoran Z; Merkel, Olaf O; Moriggl, Richard R; Grebien, Florian F; Kenner, Lukas L
Publication Date: 2016-11

Variant appearance in text: JAK3: A572V
PubMed Link: 27349799
Variant Present in the following documents:
  • Main text
View BVdb publication page



PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions.

Plos Computational Biology
Bendl, Jaroslav J; Musil, Miloš M; Štourač, Jan J; Zendulka, Jaroslav J; Damborský, Jiří J; Brezovský, Jan J
Publication Date: 2016-05

Variant appearance in text: JAK3: A572V
PubMed Link: 27224906
Variant Present in the following documents:
  • pcbi.1004962.s005.xlsx, sheet 3
View BVdb publication page



Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome Brain.

Neural Plasticity
Lee, Han-Chung HC; Tan, Kai-Leng KL; Cheah, Pike-See PS; Ling, King-Hwa KH
Publication Date: 2016

Variant appearance in text: JAK3: A572V
PubMed Link: 26881131
Variant Present in the following documents:
  • Main text
  • NP2016-7434191.pdf
View BVdb publication page



Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma.

Plos One
Simpson, Haley M HM; Khan, Rashid Z RZ; Song, Chang C; Sharma, Deva D; Sadashivaiah, Kavitha K; Furusawa, Aki A; Liu, Xinyue X; Nagaraj, Sushma S; Sengamalay, Naomi N; Sadzewicz, Lisa L; Tallon, Luke J LJ; Chen, Qing C QC; Livak, Ferenc F; Rapoport, Aaron P AP; Kimball, Amy A; Banerjee, Arnob A
Publication Date: 2015

Variant appearance in text: JAK3: A572V
PubMed Link: 26536348
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.

Oncotarget
Lee, Ji Yun JY; Park, Kyunghee K; Lim, Sung Hee SH; Kim, Hae Su HS; Yoo, Kwai Han KH; Jung, Ki Sun KS; Song, Haa-Na HN; Hong, Mineui M; Do, In-Gu IG; Ahn, TaeJin T; Lee, Se Kyung SK; Bae, Soo Youn SY; Kim, Seok Won SW; Lee, Jeong Eon JE; Nam, Seok Jin SJ; Kim, Duk-Hwan DH; Jung, Hae Hyun HH; Kim, Ji-Yeon JY; Ahn, Jin Seok JS; Im, Young-Hyuck YH; Park, Yeon Hee YH
Publication Date: 2015-12-22

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 26527317
Variant Present in the following documents:
  • oncotarget-06-43731-s002.xlsx, sheet 1
View BVdb publication page



Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.

The Journal Of Biological Chemistry
Losdyck, Elisabeth E; Hornakova, Tekla T; Springuel, Lorraine L; Degryse, Sandrine S; Gielen, Olga O; Cools, Jan J; Constantinescu, Stefan N SN; Flex, Elisabetta E; Tartaglia, Marco M; Renauld, Jean-Christophe JC; Knoops, Laurent L
Publication Date: 2015-11-27

Variant appearance in text: JAK3: A572V
PubMed Link: 26446793
Variant Present in the following documents:
  • Main text
View BVdb publication page



Patient-derived cell models as preclinical tools for genome-directed targeted therapy.

Oncotarget
Lee, Ji Yun JY; Kim, Sun Young SY; Park, Charny C; Kim, Nayoung K D NK; Jang, Jiryeon J; Park, Kyunghee K; Yi, Jun Ho JH; Hong, Mineui M; Ahn, Taejin T; Rath, Oliver O; Schueler, Julia J; Kim, Seung Tae ST; Do, In-Gu IG; Lee, Sujin S; Park, Se Hoon SH; Ji, Yong Ick YI; Kim, Dukwhan D; Park, Joon Oh JO; Park, Young Suk YS; Kang, Won Ki WK; Kim, Kyoung-Mee KM; Park, Woong-Yang WY; Lim, Ho Yeong HY; Lee, Jeeyun J
Publication Date: 2015-09-22

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 26296973
Variant Present in the following documents:
  • oncotarget-06-25619-s003.xls, sheet 1
View BVdb publication page



Development of Selective Covalent Janus Kinase 3 Inhibitors.

Journal Of Medicinal Chemistry
Tan, Li L; Akahane, Koshi K; McNally, Randall R; Reyskens, Kathleen M S E KM; Ficarro, Scott B SB; Liu, Suhu S; Herter-Sprie, Grit S GS; Koyama, Shohei S; Pattison, Michael J MJ; Labella, Katherine K; Johannessen, Liv L; Akbay, Esra A EA; Wong, Kwok-Kin KK; Frank, David A DA; Marto, Jarrod A JA; Look, Thomas A TA; Arthur, J Simon C JS; Eck, Michael J MJ; Gray, Nathanael S NS
Publication Date: 2015-08-27

Variant appearance in text: JAK3: A572V
PubMed Link: 26258521
Variant Present in the following documents:
  • Main text
View BVdb publication page



CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.

Cancer Cell
Meyer, Sara C SC; Keller, Matthew D MD; Chiu, Sophia S; Koppikar, Priya P; Guryanova, Olga A OA; Rapaport, Franck F; Xu, Ke K; Manova, Katia K; Pankov, Dmitry D; O'Reilly, Richard J RJ; Kleppe, Maria M; McKenney, Anna Sophia AS; Shih, Alan H AH; Shank, Kaitlyn K; Ahn, Jihae J; Papalexi, Eftymia E; Spitzer, Barbara B; Socci, Nick N; Viale, Agnes A; Mandon, Emeline E; Ebel, Nicolas N; Andraos, Rita R; Rubert, Joëlle J; Dammassa, Ernesta E; Romanet, Vincent V; Dölemeyer, Arno A; Zender, Michael M; Heinlein, Melanie M; Rampal, Raajit R; Weinberg, Rona Singer RS; Hoffman, Ronald R; Sellers, William R WR; Hofmann, Francesco F; Murakami, Masato M; Baffert, Fabienne F; Gaul, Christoph C; Radimerski, Thomas T; Levine, Ross L RL
Publication Date: 2015-07-13

Variant appearance in text: JAK3: A572V
PubMed Link: 26175413
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.

Blood
McGirt, Laura Y LY; Jia, Peilin P; Baerenwald, Devin A DA; Duszynski, Robert J RJ; Dahlman, Kimberly B KB; Zic, John A JA; Zwerner, Jeffrey P JP; Hucks, Donald D; Dave, Utpal U; Zhao, Zhongming Z; Eischen, Christine M CM
Publication Date: 2015-07-23

Variant appearance in text: JAK3: A572V
PubMed Link: 26082451
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay.

Oncotarget
Park, Kyunghee K; Choi, Moon Ki MK; Jung, Hae Hyun HH; Do, In-Gu IG; Lee, Kwang Hee KH; Ahn, TaeJin T; Kil, Won Ho WH; Kim, Seok Won SW; Lee, Jeong Eon JE; Nam, Seok Jin SJ; Kim, Duk-Hwan DH; Ahn, Jin Seok JS; Im, Young-Hyuck YH; Park, Yeon Hee YH
Publication Date: 2015-09-15

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 26009992
Variant Present in the following documents:
  • oncotarget-06-24499-s002.xlsx, sheet 1
View BVdb publication page



Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

Oncotarget
Lee, Seungbok S; Park, Ha Young HY; Kang, So Young SY; Kim, Seok Jin SJ; Hwang, Jinha J; Lee, Seungho S; Kwak, Soo Heon SH; Park, Kyong Soo KS; Yoo, Hae Yong HY; Kim, Won Seog WS; Kim, Jong-Il JI; Ko, Young Hyeh YH
Publication Date: 2015-07-10

Variant appearance in text: JAK3: Ala572Val
PubMed Link: 25980440
Variant Present in the following documents:
  • Main text
  • oncotarget-06-17764.pdf
View BVdb publication page



From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.

Frontiers In Oncology
Ciccone, Maria M; Calin, George A GA; Perrotti, Danilo D
Publication Date: 2015

Variant appearance in text: JAK3: A572V
PubMed Link: 25763353
Variant Present in the following documents:
  • Main text
View BVdb publication page



Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Nature Communications
Küçük, Can C; Jiang, Bei B; Hu, Xiaozhou X; Zhang, Wenyan W; Chan, John K C JK; Xiao, Wenming W; Lack, Nathan N; Alkan, Can C; Williams, John C JC; Avery, Kendra N KN; Kavak, Pınar P; Scuto, Anna A; Sen, Emel E; Gaulard, Philippe P; Staudt, Lou L; Iqbal, Javeed J; Zhang, Weiwei W; Cornish, Adam A; Gong, Qiang Q; Yang, Qunpei Q; Sun, Hong H; d'Amore, Francesco F; Leppä, Sirpa S; Liu, Weiping W; Fu, Kai K; de Leval, Laurence L; McKeithan, Timothy T; Chan, Wing C WC
Publication Date: 2015-01-14

Variant appearance in text: JAK3: A572V
PubMed Link: 25586472
Variant Present in the following documents:
  • Main text
View BVdb publication page



Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas.

Bmc Cancer
Tone, Alicia A AA; McConechy, Melissa K MK; Yang, Winnie W; Ding, Jiarui J; Yip, Stephen S; Kong, Esther E; Wong, Kwong-Kwok KK; Gershenson, David M DM; Mackay, Helen H; Shah, Sohrab S; Gilks, Blake B; Tinker, Anna V AV; Clarke, Blaise B; McAlpine, Jessica N JN; Huntsman, David D
Publication Date: 2014-12-18

Variant appearance in text: JAK3: A572V
PubMed Link: 25523272
Variant Present in the following documents:
  • 12885_2014_5198_MOESM14_ESM.xlsx, sheet 1
View BVdb publication page



High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.

Plos One
Kim, Seokhwi S; Lee, Jeeyun J; Hong, Min Eui ME; Do, In-Gu IG; Kang, So Young SY; Ha, Sang Yun SY; Kim, Seung Tae ST; Park, Se Hoon SH; Kang, Won Ki WK; Choi, Min-Gew MG; Lee, Jun Ho JH; Sohn, Tae Sung TS; Bae, Jae Moon JM; Kim, Sung S; Kim, Duk-Hwan DH; Kim, Kyoung-Mee KM
Publication Date: 2014

Variant appearance in text: JAK3: 1715C>T; A572V
PubMed Link: 25372287
Variant Present in the following documents:
  • pone.0111693.s003.xls, sheet 1
View BVdb publication page



Prospective enterprise-level molecular genotyping of a cohort of cancer patients.

The Journal Of Molecular Diagnostics : Jmd
MacConaill, Laura E LE; Garcia, Elizabeth E; Shivdasani, Priyanka P; Ducar, Matthew M; Adusumilli, Ravali R; Breneiser, Marc M; Byrne, Mark M; Chung, Lawrence L; Conneely, Jodie J; Crosby, Lauren L; Garraway, Levi A LA; Gong, Xin X; Hahn, William C WC; Hatton, Charlie C; Kantoff, Philip W PW; Kluk, Michael M; Kuo, Frank F; Jia, Yonghui Y; Joshi, Ruchi R; Longtine, Janina J; Manning, Allison A; Palescandolo, Emanuele E; Sharaf, Nematullah N; Sholl, Lynette L; van Hummelen, Paul P; Wade, Jacqueline J; Wollinson, Bruce M BM; Zepf, Dimity D; Rollins, Barrett J BJ; Lindeman, Neal I NI
Publication Date: 2014-11

Variant appearance in text: JAK3: A572V
PubMed Link: 25157968
Variant Present in the following documents:
  • Main text
View BVdb publication page



Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia.

Oncogene
Agarwal, A A; MacKenzie, R J RJ; Eide, C A CA; Davare, M A MA; Watanabe-Smith, K K; Tognon, C E CE; Mongoue-Tchokote, S S; Park, B B; Braziel, R M RM; Tyner, J W JW; Druker, B J BJ
Publication Date: 2015-06-04

Variant appearance in text: JAK3: A572V
PubMed Link: 25109334
Variant Present in the following documents:
  • Main text
View BVdb publication page



Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Lupardus, Patrick J PJ; Ultsch, Mark M; Wallweber, Heidi H; Bir Kohli, Pawan P; Johnson, Adam R AR; Eigenbrot, Charles C
Publication Date: 2014-06-03

Variant appearance in text: JAK3: A572V
PubMed Link: 24843152
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

Nature Medicine
Van Allen, Eliezer M EM; Wagle, Nikhil N; Stojanov, Petar P; Perrin, Danielle L DL; Cibulskis, Kristian K; Marlow, Sara S; Jane-Valbuena, Judit J; Friedrich, Dennis C DC; Kryukov, Gregory G; Carter, Scott L SL; McKenna, Aaron A; Sivachenko, Andrey A; Rosenberg, Mara M; Kiezun, Adam A; Voet, Douglas D; Lawrence, Michael M; Lichtenstein, Lee T LT; Gentry, Jeff G JG; Huang, Franklin W FW; Fostel, Jennifer J; Farlow, Deborah D; Barbie, David D; Gandhi, Leena L; Lander, Eric S ES; Gray, Stacy W SW; Joffe, Steven S; Janne, Pasi P; Garber, Judy J; MacConaill, Laura L; Lindeman, Neal N; Rollins, Barrett B; Kantoff, Philip P; Fisher, Sheila A SA; Gabriel, Stacey S; Getz, Gad G; Garraway, Levi A LA
Publication Date: 2014-06

Variant appearance in text: JAK3: A572V
PubMed Link: 24836576
Variant Present in the following documents:
  • Main text
View BVdb publication page



Disease-specific mutations in mature lymphoid neoplasms: recent advances.

Cancer Science
Sakata-Yanagimoto, Mamiko M; Enami, Terukazu T; Yokoyama, Yasuhisa Y; Chiba, Shigeru S
Publication Date: 2014-06

Variant appearance in text: JAK3: A572V
PubMed Link: 24689848
Variant Present in the following documents:
  • Main text
View BVdb publication page



SETting OP449 into the PP2A-activating drug family.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Neviani, Paolo P; Perrotti, Danilo D
Publication Date: 2014-04-15

Variant appearance in text: JAK3: A572V
PubMed Link: 24634375
Variant Present in the following documents:
  • Main text
View BVdb publication page



Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Agarwal, Anupriya A; MacKenzie, Ryan J RJ; Pippa, Raffaella R; Eide, Christopher A CA; Oddo, Jessica J; Tyner, Jeffrey W JW; Sears, Rosalie R; Vitek, Michael P MP; Odero, María D MD; Christensen, Dale J DJ; Druker, Brian J BJ
Publication Date: 2014-04-15

Variant appearance in text: JAK3: A572V
PubMed Link: 24436473
Variant Present in the following documents:
  • Main text
View BVdb publication page



Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.

Plos Genetics
Atak, Zeynep Kalender ZK; Gianfelici, Valentina V; Hulselmans, Gert G; De Keersmaecker, Kim K; Devasia, Arun George AG; Geerdens, Ellen E; Mentens, Nicole N; Chiaretti, Sabina S; Durinck, Kaat K; Uyttebroeck, Anne A; Vandenberghe, Peter P; Wlodarska, Iwona I; Cloos, Jacqueline J; Foà, Robin R; Speleman, Frank F; Cools, Jan J; Aerts, Stein S
Publication Date: 2013

Variant appearance in text: JAK3: A572V
PubMed Link: 24367274
Variant Present in the following documents:
  • Main text
View BVdb publication page



Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application.

Biomarker Research
Furqan, Muhammad M; Mukhi, Nikhil N; Lee, Byung B; Liu, Delong D
Publication Date: 2013-01-16

Variant appearance in text: JAK3: A572V
PubMed Link: 24252238
Variant Present in the following documents:
  • Main text
  • 2050-7771-1-5.pdf
View BVdb publication page